This may explain why markers previously associated with cancer inflammation in the literature, such as TGF-β and MIF approached but did not reach significance.
← all excerpts
An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer.
1
—
—